New research study, ProSec3, recruits first patients

February 2018

ProSec3, evaluating the clinical management of excessive saliva in patients with motor neurone disease, has opened to recruitment. Sheffield has recruited its first patients into the study, and other sites up-and-down the country (20 in total!) are primed to start recruitment very soon.

The study is jointly funded by Marie Curie and the Motor Neurone Disease Association.  

More information about the ProSec3 study